High-volume Hemofiltration Plus Hemoperfusion for Hyperlipidemic Severe Acute Pancreatitis: a Controlled Pilot Study

Overview

Journal Ann Saudi Med

Specialty General Medicine

Date 2015 Oct 29

PMID 26506968

Citations 14

Authors

Shiren Sun

Lijie He

Ming Bai

Hongbao Liu

Yangping Li

Li Li

Yan Yu

Meilan Shou

Rui Jing

Liyuan Zhao

Chen Huang

Hanmin Wang

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: The evidence for high-volume hemofiltration plus hemoperfusion (HVHF&HP) for hyperlipidemic severe acute pancreatitis (HL-SAP) is anecdotal. The purpose of our study was to evaluate the efficacy of HVHF&HP for HL-SAP in a prospective controlled study.

Design And Setting: Prospective controlled pilot study between May 2010 and May 2013 in a hospital intensive care unit.

Patients And Methods: HL-SAP patients chose conventional treatment alone (the control group) or conventional treatment combined with the experimental protocol (the HVHF&HP group) and were prospectively followed in our hospital. APACHE II score, SOFA score, ICU and hospital stay duration, and serum biomarkers were considered endpoints.

Results: Ten HL-SAP patients accepted conventional treatment alone (the control group) and 10 patients underwent HVHF&HP combined with conventional treatment (the HVHF&HP group). The APACHE II score, SOFA score, systolic blood pressure, diastolic blood pressure, heart rate, serum amylase, and serum creatinine were significantly reduced after the HVHF&HP treatment. The changes in these variables were significantly different between the HVHF&HP and control group at 48 hours after the initiation of treatment. Patients in the HVHF&HP group had a significantly shorter ICU stay (P=.015). The reduction in serum triglyceride and cholesterol in the HVHF&HP group after 2, 6, 12, 24, and 48 hours was greater than the control group. All of the tested serum cytokines were significantly decreased after HVHF&HP treatment (P < .05). However, in patients who underwent conventional treatment alone, there was no significant change in the serum cytokines.

Conclusion: This study suggests that the addition of HVHF&HP to conventional treatment for HL-SAP patients may be superior to conventional treatment alone for the improvement of serum biomarkers and clinical outcomes.

Citing Articles

Interpretable prediction of 30-day mortality in patients with acute pancreatitis based on machine learning and SHAP.

Li X, Tian Y, Li S, Wu H, Wang T BMC Med Inform Decis Mak. 2024; 24(1):328.

PMID: 39501235 PMC: 11539846. DOI: 10.1186/s12911-024-02741-7.

Assessment of triglyceride clearance of haemoperfusion from three cases of hypertriglyceridaemia-induced acute pancreatitis: a case series.

Yip W, Wu B, Ye B, Chen M, Wu Z, Ji C J Int Med Res. 2024; 52(5):3000605241252607.

PMID: 38749909 PMC: 11107382. DOI: 10.1177/03000605241252607.

Evaluating the efficacy and timing of blood purification modalities in early-stage hyperlipidemic acute pancreatitis treatment.

Wang J, Xia Y, Cao Y, Cai X, Jiang S, Liao Y Lipids Health Dis. 2023; 22(1):208.

PMID: 38031159 PMC: 10685498. DOI: 10.1186/s12944-023-01968-z.

Hypertriglyceridemia may contribute to stroke and pancreatitis: A case report and review of the literature.

Zhang M, Yin T, Xia F, Xia S, Zhou W, Zhang Y Front Endocrinol (Lausanne). 2022; 13:960343.

PMID: 36531479 PMC: 9751361. DOI: 10.3389/fendo.2022.960343.

Hypertriglyceridemia induced acute pancreatitis: 4 years' experience from a tertiary care institute and quick literature review.

Kumar B, Prasad K, Singh D, Sethy P J Family Med Prim Care. 2022; 11(6):3360-3367.

PMID: 36119312 PMC: 9480712. DOI: 10.4103/jfmpc.jfmpc_1426_21.

References

Ronco C, Tetta C, Mariano F, Wratten M, Bonello M, Bordoni V . Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs. 2003; 27(9):792-801. DOI: 10.1046/j.1525-1594.2003.07289.x. View

Kadikoylu G, Yavasoglu I, Bolaman Z . Plasma exchange in severe hypertriglyceridemia a clinical study. Transfus Apher Sci. 2006; 34(3):253-7. DOI: 10.1016/j.transci.2005.11.009. View

van Santvoort H, Besselink M, Bakker O, Hofker H, Boermeester M, Dejong C . A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med. 2010; 362(16):1491-502. DOI: 10.1056/NEJMoa0908821. View

Mao E, Tang Y, Zhang S . Formalized therapeutic guideline for hyperlipidemic severe acute pancreatitis. World J Gastroenterol. 2003; 9(11):2622-6. PMC: 4656556. DOI: 10.3748/wjg.v9.i11.2622. View

Hen K, Bogdanski P, Pupek-Musialik D . [Successful treatment of severe hypertriglyceridemia with plasmapheresis--case report]. Pol Merkur Lekarski. 2009; 26(151):62-4. View

Iskandar S, Olive K . Plasmapheresis as an adjuvant therapy for hypertriglyceridemia-induced pancreatitis. Am J Med Sci. 2004; 328(5):290-4. DOI: 10.1097/00000441-200411000-00010. View

Fortson M, Freedman S, WEBSTER 3rd P . Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol. 1995; 90(12):2134-9. View

Yadav D, Pitchumoni C . Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol. 2002; 36(1):54-62. DOI: 10.1097/00004836-200301000-00016. View

Mao H, Yu S, Yu X, Zhang B, Zhang L, Xu X . Effects of coupled plasma filtration adsorption on immune function of patients with multiple organ dysfunction syndrome. Int J Artif Organs. 2009; 32(1):31-8. DOI: 10.1177/039139880903200104. View

10.

Saotome T, Endo Y, Sasaki T, Tabata T, Hamamoto T, Fujino K . A case of severe acute pancreatitis treated with CTR-001 direct hemoperfusion for cytokine apheresis. Ther Apher Dial. 2005; 9(4):367-71. DOI: 10.1111/j.1744-9987.2005.00299.x. View

11.

Kyriakidis A, Raitsiou B, Sakagianni A, Harisopoulou V, Pyrgioti M, Panagopoulou A . Management of acute severe hyperlipidemic pancreatitis. Digestion. 2006; 73(4):259-64. DOI: 10.1159/000095425. View

12.

Toouli J, Brooke-Smith M, Bassi C, Carr-Locke D, Telford J, Freeny P . Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol. 2002; 17 Suppl:S15-39. DOI: 10.1046/j.1440-1746.17.s1.2.x. View

13.

Saravanan P, Blumenthal S, Anderson C, Stein R, Berkelhammer C . Plasma exchange for dramatic gestational hyperlipidemic pancreatitis. J Clin Gastroenterol. 1996; 22(4):295-8. DOI: 10.1097/00004836-199606000-00011. View

14.

Kobe Y, Oda S, Matsuda K, Nakamura M, Hirasawa H . Direct hemoperfusion with a cytokine-adsorbing device for the treatment of persistent or severe hypercytokinemia: a pilot study. Blood Purif. 2007; 25(5-6):446-53. PMC: 2813796. DOI: 10.1159/000111568. View

15.

Chang M, Su C, Sun M, Huang S, Chiu C, Chen M . Etiology of acute pancreatitis--a multi-center study in Taiwan. Hepatogastroenterology. 2003; 50(53):1655-7. View

16.

Dominguez-Munoz J, Junemann F, Malfertheiner P . Hyperlipidemia in acute pancreatitis. Cause or epiphenomenon?. Int J Pancreatol. 1995; 18(2):101-6. DOI: 10.1007/BF02785883. View

17.

Bone R, Balk R, Cerra F, Dellinger R, Fein A, Knaus W . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101(6):1644-55. DOI: 10.1378/chest.101.6.1644. View

18.

Murphy M, Sheng X, MacDonald T, Wei L . Hypertriglyceridemia and acute pancreatitis. JAMA Intern Med. 2012; 173(2):162-4. DOI: 10.1001/2013.jamainternmed.477. View

19.

Tsuang W, Navaneethan U, Ruiz L, Palascak J, Gelrud A . Hypertriglyceridemic pancreatitis: presentation and management. Am J Gastroenterol. 2009; 104(4):984-91. DOI: 10.1038/ajg.2009.27. View

20.

Nair S, Yadav D, Pitchumoni C . Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am J Gastroenterol. 2000; 95(10):2795-800. DOI: 10.1111/j.1572-0241.2000.03188.x. View